Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Frank Merola, M.D.

Title
Institution
Department
Address
Phone
Fax

Overview
Clinically trained in internal medicine (board certified - ABIM), dermatology (board certified- ABD) and rheumatology (active fellow); interest in rhematology-dermatology overlap diseases (lupus, dermatomyositis, scleroderma, psoriasis/psoriatic arthritis, vasculitis).
Clinical translational research interest in autoimmunity broadly and in the diseases listed above; current MMSc student in the Harvard Clinical Scholars Program.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo RV, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020 Sep 03. PMID: 32891785.
    Citations:    
  2. Coates LC, Merola JF, Mease PJ, Ogdie A, Gladman DD, Strand V, van Mens LJJ, Liu L, Yen PK, Collier DH, Kricorian G, Chung JB, Helliwell PS. Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology (Oxford). 2020 Aug 30. PMID: 32864685.
    Citations:    
  3. Klebanov N, Perez-Chada LM, Gupta S, Gottlieb AB, Merola JF. Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: a safety surrogate to predict cancer survival associated with biologic therapies. J Am Acad Dermatol. 2020 Aug 18. PMID: 32822791.
    Citations:    
  4. Rich P, Goldblum O, Disch D, Lin CY, Merola JF, Elewski B. Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis. J Drugs Dermatol. 2020 Aug 01; 19(8):741-746. PMID: 32845588.
    Citations:    
  5. Elman SA, Joyce C, Braudis K, Chong BF, Fernandez AP, Furukawa F, Hasegawa M, Kim HJ, Li SJ, Lian CG, Szepietowski JC, Werth VP, Merola JF. Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus. JAMA Dermatol. 2020 Aug 01; 156(8):901-906. PMID: 32584927.
    Citations:    
  6. Wu JJ, Merola JF, Feldman SR, Menter A, Lebwohl M. Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence. Dermatol Ther (Heidelb). 2020 Aug; 10(4):901. PMID: 32419098.
    Citations:    
  7. Gottlieb AB, Merola JF. Axial psoriatic arthritis: An update for dermatologists. J Am Acad Dermatol. 2020 Jul 31. PMID: 32747079.
    Citations:    
  8. Tillett W, Merola JF, Thaçi D, Holdsworth E, Booth N, Lobosco LS, Milligan G, Hufford MM, Birt JA, Boehncke WH. Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey. Rheumatol Ther. 2020 Sep; 7(3):617-637. PMID: 32700230.
    Citations:    
  9. Zahedi Niaki O, Anadkat MJ, Chen ST, Fox LP, Harp J, Micheletti RG, Nambudiri VE, Pasieka HB, Shinohara MM, Rosenbach M, Merola JF. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists. J Am Acad Dermatol. 2020 Oct; 83(4):1150-1159. PMID: 32569797.
    Citations:    
  10. Schneeweiss MC, Merola JF, Schneeweiss S, Wyss R, Rosmarin D. Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020 Jun 12. PMID: 32531094.
    Citations:    
  11. Aletaha D, Husni ME, Merola JF, Ranza R, Bertheussen H, Lippe R, Young PM, Cappelleri JC, Brown TM, Ervin C, Hsu MA, Fallon L. Treatment Mode Preferences in Psoriatic Arthritis: A Qualitative Multi-Country Study. Patient Prefer Adherence. 2020; 14:949-961. PMID: 32606613.
    Citations:    
  12. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting. J Rheumatol Suppl. 2020 Jun; 96:36-40. PMID: 32482766.
    Citations:    
  13. Coates LC, Merola JF, Grieb SM, Mease PJ, Callis Duffin K. Methotrexate in Psoriasis and Psoriatic Arthritis. J Rheumatol Suppl. 2020 Jun; 96:31-35. PMID: 32482765.
    Citations:    
  14. Perez-Chada LM, Salame NF, Ford AR, Duffin KC, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. Am J Clin Dermatol. 2020 Jun; 21(3):323-338. PMID: 31950353.
    Citations:    
  15. Blauvelt A, Papp KA, Merola JF, Gottlieb AB, Cross N, Madden C, Wang M, Cioffi C, Griffiths CEM. Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study. J Am Acad Dermatol. 2020 May 29. PMID: 32473974.
    Citations:    
  16. Weber B, Perez-Chada LM, Divakaran S, Brown JM, Taqueti V, Dorbala S, Blankstein R, Liao K, Merola JF, Di Carli M. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2020 May 17. PMID: 32419071.
    Citations:    
  17. Schneeweiss MC, Perez Chada L, Gottlieb AB, Merola JF. Older adults on systemic treatment for psoriasis and risk of infection: a propensity score-matched population-based study. Br J Dermatol. 2020 Sep; 183(3):564-566. PMID: 32159850.
    Citations:    
  18. Merola JF, Sidbury R, Wollenberg A, Chen Z, Zhang A, Shumel B, Rossi AB. Dupilumab prevents flares in adults with moderate-to-severe atopic dermatitis in a 52-week randomized controlled phase 3 trial. J Am Acad Dermatol. 2020 May 06. PMID: 32387659.
    Citations:    
  19. Tkachenko E, Steuer AB, Lo K, LaChance A, Merola JF, Femia AN, Vleugels RA. Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers. JAMA Dermatol. 2020 May 01; 156(5):595-597. PMID: 32236487.
    Citations:    
  20. Merola JF, Papp KA, Nash P, Gratacós J, Boehncke WH, Thaçi D, Graham D, Hsu MA, Wang C, Wu J, Young P. Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studies. J Eur Acad Dermatol Venereol. 2020 Apr 09. PMID: 32271970.
    Citations:    
  21. Wu JJ, Merola JF, Feldman SR, Menter A, Lebwohl M. Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence. Dermatol Ther (Heidelb). 2020 Jun; 10(3):351-364. PMID: 32242325.
    Citations:    
  22. Choong CK, Merola JF, Han J, Li X. Indoor tanning use is associated with psoriasis in the Nurses' Health Study II. Br J Dermatol. 2020 Aug; 183(2):384-386. PMID: 32078156.
    Citations:    
  23. Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol. 2020 May; 214:108397. PMID: 32229290.
    Citations:    
  24. Schneeweiss MC, Huang JT, Wyss R, Schneeweiss S, Merola JF. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study. J Am Acad Dermatol. 2020 Jun; 82(6):1337-1345. PMID: 32142748.
    Citations:    
  25. Schneeweiss MC, Kim SC, Schneeweiss S, Rosmarin D, Merola JF. Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa. JAMA Dermatol. 2020 Mar 01; 156(3):342-345. PMID: 31968066.
    Citations:    
  26. Perez-Chada LM, Balak D, Cohen JM, Ogdie A, Merola JF, Gottlieb AB. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Expert Rev Clin Immunol. 2020 Mar; 16(3):267-283. PMID: 32037912.
    Citations:    
  27. Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Gottlieb AB, Assudani D, Bedford-Rice K, Coarse J, Ink B, McInnes IB. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2020 02 08; 395(10222):427-440. PMID: 32035552.
    Citations:    
  28. Merola JF, Perez Chada LM, Siegel M, Bagel J, Evans C, Lockshin B, Mason M, Guo N, McLean RR, Greenberg JD, Van Voorhees AS. The National Psoriasis Foundation psoriasis treatment targets in real-world patients: prevalence and association with patient-reported outcomes in the Corrona Psoriasis Registry. J Eur Acad Dermatol Venereol. 2020 Feb 06. PMID: 32027420.
    Citations:    
  29. Merola JF, Ghislain PD, Dauendorffer JN, Potts Bleakman A, Brnabic AJM, Burge R, Riedl E. Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):1257-1262. PMID: 31919919.
    Citations:    
  30. Natsis NE, Merola JF, Weinberg JM, Wu JJ, Orbai AM, Bagel J, Gottlieb AB. Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or Apremilast. Am J Clin Dermatol. 2020 Feb; 21(1):109-117. PMID: 31452091.
    Citations:    
  31. Kornmehl H, Callis Duffin K, Salame N, Perez-Chada LM, Singh S, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM). Dermatology. 2020 Jan 28; 1-7. PMID: 31991410.
    Citations:    
  32. Merola J, Selezneva L, Perkins R, Lang J, Barry J, Leach P. Cerebrospinal fluid diversion versus bariatric surgery in the management of idiopathic intracranial hypertension. Br J Neurosurg. 2020 Feb; 34(1):9-12. PMID: 31805794.
    Citations:    
  33. Feldman CH, Speyer C, Ashby R, Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH. Development of a Set of Lupus-Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken). 2019 Oct 18. PMID: 31628721.
    Citations:    
  34. Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, Merola JF, Fiorentino D, Dutz JP, Goodfield M, Nyberg F, Volc-Platzer B, Fujimoto M, Ang CC, Werth VP. Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. Br J Dermatol. 2020 02; 182(2):410-417. PMID: 31049930.
    Citations:    
  35. Perez-Chada L, Taliercio VL, Gottlieb A, Van Beek M, Duffin KC, Reeder M, Merola JF, Swerlick RA. Achieving Consensus on Patient-Reported Outcome Measures in Clinical Practice for Inflammatory Skin Disorders: On Behalf of International Dermatology Outcome Measures and the American Academy of Dermatology. J Am Acad Dermatol. 2019 Sep 13. PMID: 31525439.
    Citations:    
  36. Skougaard M, Jørgensen TS, Rifbjerg-Madsen S, Coates LC, Egeberg A, Amris K, Dreyer L, Højgaard P, Guldberg-Møller J, Merola JF, Frederiksen P, Gudbergsen H, Kristensen LE. Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study. J Rheumatol. 2020 04; 47(4):548-552. PMID: 31308213.
    Citations:    
  37. Merola JF, Ogdie A. SEAM-PsA: Seems Like Methotrexate Works in Psoriatic Arthritis? Arthritis Rheumatol. 2019 07; 71(7):1027-1029. PMID: 30816631.
    Citations:    
  38. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting. J Rheumatol Suppl. 2019 Jun; 95:28-32. PMID: 31154401.
    Citations:    
  39. Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. J Am Acad Dermatol. 2020 Jan; 82(1):54-61. PMID: 31163240.
    Citations:    
  40. Schneeweiss MC, Perez-Chada L, Merola JF. Comparative Safety of Systemic Immuno-modulatory Medications in Adults with Atopic Dermatitis. J Am Acad Dermatol. 2019 May 31. PMID: 31158390.
    Citations:    
  41. Gottlieb AB, Germino R, Herrera V, Meng X, Merola JF. Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis. Dermatology. 2019; 235(4):348-354. PMID: 31141807.
    Citations:    
  42. Elman SA, Joyce C, Costenbader KH, Merola JF. Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study. Clin Exp Dermatol. 2020 Jan; 45(1):89-91. PMID: 31120600.
    Citations:    
  43. Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J, Shuler CL, Hufford MM, Thaçi D. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis. 2019 09; 78(9):1215-1219. PMID: 31113794.
    Citations:    
  44. Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat. 2020 Nov; 31(7):662-679. PMID: 31014154.
    Citations:    
  45. Johnson CM, Fitch K, Merola JF, Han J, Qureshi AA, Li WQ. Plasma levels of tumour necrosis factor-a and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasis. Br J Dermatol. 2019 08; 181(2):379-380. PMID: 30695115.
    Citations:    Fields:    
  46. Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019 Jul; 81(1):102-110. PMID: 30885757.
    Citations:    
  47. Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019 03; 15(3):153-166. PMID: 30742092.
    Citations:    
  48. Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, Wang W, Christmann R, Gardet A, Pellerin A, Hamann S, Auluck P, Barbey C, Gulati P, Rabah D, Franchimont N. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest. 2019 03 01; 129(3):1359-1371. PMID: 30645203.
    Citations:    Fields:    
  49. Merola JF, Shrom D, Eaton J, Dworkin C, Krebsbach C, Shah-Manek B, Birt J. Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey. Rheumatol Ther. 2019 Mar; 6(1):33-45. PMID: 30610650.
    Citations:    
  50. Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019 01; 71(1):5-32. PMID: 30499246.
    Citations:    Fields:    
  51. Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019 01; 71(1):2-29. PMID: 30499259.
    Citations:    Fields:    
  52. Li SJ, Perez-Chada LM, Merola JF. TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management. J Psoriasis Psoriatic Arthritis. 2019 Apr; 4(2):70-80. PMID: 31093599.
    Citations:    
  53. Haberman R, Perez-Chada LM, Merola JF, Scher J, Ogdie A, Reddy SM. Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics. Curr Rheumatol Rep. 2018 10 26; 20(12):76. PMID: 30367311.
    Citations:    Fields:    
  54. Coates LC, Gottlieb AB, Merola JF, Boone C, Szumski A, Chhabra A. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value. J Rheumatol. 2019 02; 46(2):160-165. PMID: 30323006.
    Citations:    Fields:    
  55. Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials. JAMA Dermatol. 2018 10 01; 154(10):1137-1144. PMID: 29874367.
    Citations:    Fields:    
  56. Gottlieb A, Salame N, Armstrong AW, Merola JF, Parra S, Takeshita J, Chen SC, Latella J, Van Beek M. A provider global assessment quality measure for clinical practice for inflammatory skin disorders. J Am Acad Dermatol. 2019 03; 80(3):823-828. PMID: 30244058.
    Citations:    Fields:    
  57. Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 02; 80(2):577-578. PMID: 30244066.
    Citations:    Fields:    
  58. Concha JSS, Patsatsi A, Marshak-Rothstein A, Liu ML, Sinha AA, Lee LA, Merola JF, Jabbari A, Gudjonsson JE, Chasset F, Jarrett P, Chong B, Arkin L, Fernandez AP, Caproni M, Greenberg SA, Kim HJ, Pearson DR, Femia A, Vleugels RA, Fiorentino D, Fujimoto M, Wenzel J, Werth VP. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. J Invest Dermatol. 2019 02; 139(2):270-276. PMID: 30243657.
    Citations:    Fields:    
  59. Elman SA, Weinblatt M, Merola JF. Targeted therapies for psoriatic arthritis: an update for the dermatologist. Semin Cutan Med Surg. 2018 Sep; 37(3):173-181. PMID: 30215635.
    Citations:    Fields:    
  60. Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Arch Dermatol Res. 2018 Nov; 310(9):701-710. PMID: 30167814.
    Citations:    Fields:    
  61. Salame N, Perez-Chada LM, Singh S, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis. Dermatology. 2018; 234(5-6):157-165. PMID: 30121657.
    Citations:    Fields:    
  62. Merola JF, Espinoza LR, Fleischmann R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open. 2018; 4(2):e000656. PMID: 30167326.
    Citations:    
  63. Ford AR, Siegel M, Bagel J, Cordoro KM, Garg A, Gottlieb A, Green LJ, Gudjonsson JE, Koo J, Lebwohl M, Liao W, Mandelin AM, Markenson JA, Mehta N, Merola JF, Prussick R, Ryan C, Schwartzman S, Siegel EL, Van Voorhees AS, Wu JJ, Armstrong AW. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA Dermatol. 2018 08 01; 154(8):934-950. PMID: 29926091.
    Citations:    Fields:    
  64. Merola JF, Herrera V, Palmer JB. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA. Clin Rheumatol. 2018 Oct; 37(10):2751-2761. PMID: 30051284.
    Citations:    Fields:    Translation:Humans
  65. Murage MJ, Anderson A, Casso D, Oliveria SA, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB. Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity. J Dermatolog Treat. 2019 Mar; 30(2):141-149. PMID: 29799292.
    Citations:    Fields:    
  66. Ryan C, Menter A, Guenther L, Blauvelt A, Bissonnette R, Meeuwis K, Sullivan J, Cather JC, Yosipovitch G, Gottlieb AB, Merola JF, Callis Duffin K, Fretzin S, Osuntokun OO, Burge R, Naegeli AN, Yang FE, Lin CY, Todd K, Potts Bleakman A. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis. Br J Dermatol. 2018 10; 179(4):844-852. PMID: 29747232.
    Citations:    Fields:    
  67. Salame N, Torres J, Sandhu J, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). Dermatology. 2018; 234(3-4):112-119. PMID: 31112972.
    Citations:    
  68. de Vlam K, Merola JF, Birt JA, Sandoval DM, Lobosco S, Moon R, Milligan G, Boehncke WH. Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study. Rheumatol Ther. 2018 Dec; 5(2):423-436. PMID: 29980935.
    Citations:    
  69. Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A, Jemec GBE. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018 09; 179(3):642-650. PMID: 29654696.
    Citations:    Fields:    
  70. Callis Duffin K, FitzGerald O, Kavanaugh A, Mease PJ, Merola JF, Ogdie A, O'Sullivan D, Reddy SM, Ritchlin CT, Coates LC. GRAPPA 2017 Project Report. J Rheumatol Suppl. 2018 Jun; 94:48-51. PMID: 29858355.
    Citations:    Fields:    Translation:Humans
  71. Gottlieb AB, Coates LC, van Mens LJJ, Armstrong AW, Merola JF. Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting. J Rheumatol Suppl. 2018 Jun; 94:40-43. PMID: 29858353.
    Citations:    Fields:    Translation:Humans
  72. Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity. J Med Econ. 2018 Aug; 21(8):745-754. PMID: 29718756.
    Citations:    Fields:    Translation:Humans
  73. Zhang A, Kurtzman DJB, Perez-Chada LM, Merola JF. Psoriatic arthritis and the dermatologist: An approach to screening and clinical evaluation. Clin Dermatol. 2018 Jul - Aug; 36(4):551-560. PMID: 30047437.
    Citations:    Fields:    Translation:Humans
  74. Singer SB, Thomas C, Lezcano C, Robbins M, Gordian A, Nori S, Granter SR, Merola JF, O'Malley JT. Polyarthralgias and Papulonodules in a 56-Year-Old Woman. Arthritis Care Res (Hoboken). 2018 06; 70(6):925-930. PMID: 29342504.
    Citations:    Fields:    
  75. Fazel M, Merola JF, Kurtzman DJB. Inflammatory arthritis and crystal arthropathy: Current concepts of skin and systemic manifestations. Clin Dermatol. 2018 Jul - Aug; 36(4):533-550. PMID: 30047436.
    Citations:    Fields:    Translation:Humans
  76. Papp KA, Merola JF, Gottlieb AB, Griffiths CEM, Cross N, Peterson L, Cioffi C, Blauvelt A. Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial. J Am Acad Dermatol. 2018 Aug; 79(2):277-286.e10. PMID: 29609013.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  77. Merrill JT, Manzi S, Aranow C, Askanase A, Bruce I, Chakravarty E, Chong B, Costenbader K, Dall'Era M, Ginzler E, Hanrahan L, Kalunian K, Merola J, Raymond S, Rovin B, Saxena A, Werth VP. Lupus community panel proposals for optimising clinical trials: 2018. Lupus Sci Med. 2018; 5(1):e000258. PMID: 29657738.
    Citations: 1     
  78. Lee MP, Lii J, Jin Y, Desai RJ, Solomon DH, Merola JF, Kim SC. Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 05; 70(5):791-796. PMID: 28804988.
    Citations:    Fields:    
  79. Merola JF, Amato DA, See K, Burge R, Mallinckrodt C, Ojeh CK, Gottlieb A. Evaluation of sPGA × BSA as an Outcome Measure and Treatment Target for Clinical Practice. J Invest Dermatol. 2018 09; 138(9):1955-1961. PMID: 29577919.
    Citations:    Fields:    
  80. Song P, Fett NM, Lin J, Merola JF, Costner M, Vleugels RA. Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis. Br J Dermatol. 2018 06; 178(6):1412-1415. PMID: 28667747.
    Citations:    Fields:    
  81. Merola JF, Qureshi A, Husni ME. Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatol Ther. 2018 05; 31(3):e12589. PMID: 29512290.
    Citations:    Fields:    Translation:Humans
  82. Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018 Aug; 79(2):345-352. PMID: 29477740.
    Citations: 2     Fields:    Translation:Humans
  83. Dewan AK, Pinard J, Jadeja S, Granter S, Merola JF. Erythema elevatum diutinum-like vasculitis secondary to cocaine adulterated with levamisole. Clin Exp Dermatol. 2018 Jun; 43(4):494-496. PMID: 29423942.
    Citations:    Fields:    Translation:HumansPHPublic Health
  84. Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Arthritis Rheumatol. 2018 03; 70(3):345-355. PMID: 29193765.
    Citations: 3     Fields:    Translation:Humans
  85. Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernández-Peñas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens EP, Randell S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018 03; 178(3):715-721. PMID: 29080368.
    Citations: 1     Fields:    
  86. Whitlock SM, Enos CW, Armstrong AW, Gottlieb A, Langley RG, Lebwohl M, Merola JF, Ryan C, Siegel MP, Weinberg JM, Wu JJ, Van Voorhees AS. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2018 02; 78(2):383-394. PMID: 29332708.
    Citations:    Fields:    Translation:Humans
  87. Pinard J, Patel M, Granter SR, Vleugels RA, Merola JF. Subacute Cutaneous Lupus Erythematosus Induced by Palbociclib. J Cutan Med Surg. 2018 May/Jun; 22(3):341-343. PMID: 29307217.
    Citations:    Fields:    Translation:Humans
  88. Pinard J, Vleugels RA, Joyce C, Merola JF, Patel M. Hidradenitis suppurativa burden of disease tool: Pilot testing of a disease-specific quality of life questionnaire. J Am Acad Dermatol. 2018 01; 78(1):215-217.e2. PMID: 29241793.
    Citations:    Fields:    Translation:Humans
  89. Pinard J, Chiang DY, Mostaghimi A, Granter SR, Merola JF, Barkoudah E. Wounds That Would Not Heal: Pyoderma Gangrenosum. Am J Med. 2018 04; 131(4):377-379. PMID: 29284112.
    Citations:    Fields:    
  90. Gottlieb AB, Merola JF, Chen R, Levi E, Duffin KC. Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. J Am Acad Dermatol. 2017 Dec; 77(6):1178-1180. PMID: 29132853.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  91. Ko LN, Pinard J, Merola JF, Patel M. Novel posterior auricular cutaneous reaction after anti-TNF-a infusion in young women with Crohn's disease. JAAD Case Rep. 2017 Nov; 3(6):512-514. PMID: 29296639.
    Citations:    
  92. Concha JSS, Merola JF, Fiorentino D, Werth VP. Re-examining mechanic's hands as a characteristic skin finding in dermatomyositis. J Am Acad Dermatol. 2018 04; 78(4):769-775.e2. PMID: 29102487.
    Citations:    Fields:    Translation:Humans
  93. Mease P, Hall S, FitzGerald O, van der Heijde D, Merola JF, Avila-Zapata F, Cieslak D, Graham D, Wang C, Menon S, Hendrikx T, Kanik KS. Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis. N Engl J Med. 2017 10 19; 377(16):1537-1550. PMID: 29045212.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  94. Fruchter R, Kurtzman DJB, Patel M, Merola J, Franks AG, Vleugels RA, Femia AN. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus. JAMA Dermatol. 2017 09 01; 153(9):937-939. PMID: 28636714.
    Citations:    Fields:    Translation:Humans
  95. Gunasekera NS, Maniar LEG, Lezcano C, Laga AC, Merola JF. Intralesional Sodium Thiosulfate Treatment for Calcinosis Cutis in the Setting of Lupus Panniculitis. JAMA Dermatol. 2017 09 01; 153(9):944-945. PMID: 28564698.
    Citations:    Fields:    Translation:Humans
  96. Schneeweiss M, Merola JF, Karlson EW, Solomon DH. Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR). BMC Dermatol. 2017 08 16; 17(1):11. PMID: 28814312.
    Citations:    Fields:    Translation:Humans
  97. Khosravi H, Siegel MP, Van Voorhees AS, Merola JF. Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. J Drugs Dermatol. 2017 Aug 01; 16(8):760-766. PMID: 28809991.
    Citations:    Fields:    Translation:Humans
  98. Perez-Chada LM, Singh S, Callis-Duffin K, Garg A, Gottlieb AB, Latella J, Armstrong AW, Merola JF. International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working Group. J Drugs Dermatol. 2017 Aug 01; 16(8):770-777. PMID: 28809992.
    Citations:    Fields:    Translation:Humans
  99. Merola JF, Bleakman AP, Gottlieb AB, Menter A, Naegeli AN, Bissonnette R, Guenther L, Sullivan J, Meeuwis K, See K, Duffin KC. The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis. J Drugs Dermatol. 2017 Aug 01; 16(8):793-799. PMID: 28809994.
    Citations:    Fields:    Translation:Humans
  100. Jain A, Correia J, Schweder P, McMahon A, Merola J, Aspoas R. Analysis of Outcomes of Multidisciplinary Management of Gliosarcoma: A Single-Center Study, 2000-2013. World Neurosurg. 2017 Oct; 106:30-36. PMID: 28642179.
    Citations: 1     Fields:    Translation:Humans
  101. Elman SA, Joyce C, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, Marinovic B, Szepietowski JC, Dutz J, Werth VP, Merola JF. Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise. J Am Acad Dermatol. 2017 Aug; 77(2):261-267. PMID: 28606712.
    Citations: 1     Fields:    Translation:Humans
  102. Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017 12; 47(3):351-360. PMID: 28802776.
    Citations: 1     Fields:    Translation:Humans
  103. Favier G, Gladman DD, Merola JF, Armstrong AW, Boehncke WH, Helliwell PS. Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):674-678. PMID: 28461523.
    Citations: 1     Fields:    Translation:Humans
  104. Merola JF, Gottlieb AB. Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):691-692. PMID: 28461528.
    Citations:    Fields:    Translation:Humans
  105. Okhovat JP, Ogdie A, Reddy SM, Rosen CF, Scher JU, Merola JF. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics. J Rheumatol. 2017 05; 44(5):693-694. PMID: 28461529.
    Citations: 2     Fields:    Translation:Humans
  106. Kaskas N, Merola JF, Qureshi AA, Paek SY. Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):695-696. PMID: 28461530.
    Citations:    Fields:    Translation:Humans
  107. Callis Duffin K, Gottlieb AB, Merola JF, Latella J, Garg A, Armstrong AW. Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):701-702. PMID: 28461532.
    Citations:    Fields:    Translation:Humans
  108. Menter A, Warren RB, Langley RG, Merola JF, Kerr LN, Dennehy EB, Shrom D, Amato D, Okubo Y, Reich K. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1686-1692. PMID: 28322474.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  109. Merola JF, Elewski B, Tatulych S, Lan S, Tallman A, Kaur M. Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2017 Jul; 77(1):79-87.e1. PMID: 28396102.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  110. Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GB. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open. 2017 02 20; 7(2):e014733. PMID: 28219961.
    Citations: 4     Fields:    Translation:Humans
  111. Haber JS, Merola JF, Werth VP. Classifying discoid lupus erythematosus: background, gaps, and difficulties. Int J Womens Dermatol. 2017 Mar; 3(1 Suppl):S62-S66. PMID: 28492042.
    Citations:    
  112. Merola JF, Lockshin B, Mody EA. Switching biologics in the treatment of psoriatic arthritis. Semin Arthritis Rheum. 2017 08; 47(1):29-37. PMID: 28363434.
    Citations: 4     Fields:    Translation:Humans
  113. Elman SA, Merola JF, Armstrong AW, Duffin KC, Latella J, Garg A, Gottlieb AB. The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update. J Drugs Dermatol. 2017 Feb 01; 16(2):119-124. PMID: 28300853.
    Citations: 2     Fields:    Translation:Humans
  114. Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS. From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017 Feb; 76(2):290-298. PMID: 27908543.
    Citations: 4     Fields:    Translation:Humans
  115. Merola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. Transplant Proc. 2016 Nov; 48(9):3106-3108. PMID: 27932157.
    Citations: 1     Fields:    Translation:Humans
  116. Kurtzman DJ, Wright NA, Lin J, Femia AN, Merola JF, Patel M, Vleugels RA. Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment. JAMA Dermatol. 2016 08 01; 152(8):944-5. PMID: 27120749.
    Citations: 8     Fields:    Translation:Humans
  117. Cohen JM, Halim K, Joyce CJ, Patel M, Qureshi AA, Merola JF. Shedding Light on the "Hidden Psoriasis": A Pilot Study of the Inverse Psoriasis Burden of Disease (IPBOD) Questionnaire. J Drugs Dermatol. 2016 Aug 01; 15(8):1011-6. PMID: 27538004.
    Citations: 1     Fields:    Translation:Humans
  118. Elman SA, Ware JH, Gottlieb AB, Merola JF. Adaptive Clinical Trial Design: An Overview and Potential Applications in Dermatology. J Invest Dermatol. 2016 07; 136(7):1325-1329. PMID: 27157773.
    Citations: 1     Fields:    Translation:Humans
  119. Merola JF, Armstrong AW, Saraiya A, Latella J, Garg A, Callis Duffin K, Gottlieb AB. International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update. J Rheumatol. 2016 05; 43(5):959-60. PMID: 27134269.
    Citations: 1     Fields:    Translation:Humans
  120. Paek SY, Thompson JM, Qureshi AA, Merola JF, Husni ME. Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting. J Rheumatol. 2016 05; 43(5):961-4. PMID: 27134270.
    Citations: 1     Fields:    Translation:Humans
  121. Greb JE, Merola J, Garg A, Latella J, Howard L, Acharya N, Gottlieb AB. The Psoriatic Disease Payer Advisory Panel. J Drugs Dermatol. 2016 May 01; 15(5):641-4. PMID: 27168273.
    Citations: 1     Fields:    Translation:Humans
  122. Xue Y, Cohen JM, Wright NA, Merola JF. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects. Am J Clin Dermatol. 2016 Apr; 17(2):147-62. PMID: 26649439.
    Citations: 3     Fields:    Translation:Humans
  123. Haber JS, Merola JF, Werth VP. Classifying discoid lupus erythematosus: background, gaps, and difficulties. Int J Womens Dermatol. 2016 Mar; 2(1):8-12. PMID: 28491994.
    Citations: 1     
  124. Elman SA, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP, Merola JF. Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meeting. Int J Womens Dermatol. 2016 Jun; 2(2):44-45. PMID: 28492003.
    Citations:    
  125. Merola JF, Li T, Li WQ, Cho E, Qureshi AA. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol. 2016 Jul; 41(5):486-9. PMID: 26890045.
    Citations: 5     Fields:    Translation:Humans
  126. Song JS, Halim K, Vleugels RA, Merola JF. Dapsone for treatment of erythema nodosum. Dermatol Online J. 2016 Feb 17; 22(2). PMID: 27267197.
    Citations:    Fields:    Translation:Humans
  127. Timerman D, Devlin PM, Nambudiri VE, Wright NA, Vleugels RA, Clark RA, Kupper TS, Merola JF, Patel M. Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. Clin Exp Dermatol. 2016 Jul; 41(5):498-501. PMID: 26848819.
    Citations:    Fields:    Translation:Humans
  128. Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and Treatment of Eosinophilic Fasciitis: An Analysis of 63 Patients From 3 Tertiary Care Centers. JAMA Dermatol. 2016 Jan; 152(1):97-9. PMID: 26559760.
    Citations: 6     Fields:    Translation:Humans
  129. Sheu JS, Divito SJ, Enamandram M, Merola JF. Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature. Dermatology. 2016; 232(1):97-101. PMID: 26465742.
    Citations:    Fields:    Translation:Humans
  130. Patel M, Cohen JM, Wright NA, Merola JF, Qureshi AA, Vleugels RA. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center. J Am Acad Dermatol. 2015 Oct; 73(4):701-2. PMID: 26369843.
    Citations: 2     Fields:    Translation:Humans
  131. Jung DH, Nadol JB, Folkerth RD, Merola JF. Histopathology of the Inner Ear in a Case With Recent Onset of Cogan's Syndrome: Evidence for Vasculitis. Ann Otol Rhinol Laryngol. 2016 Jan; 125(1):20-4. PMID: 26195577.
    Citations: 5     Fields:    Translation:Humans
  132. Geller BJ, Stone RM, Merola JF, Levy BD, Loscalzo J. CLINICAL PROBLEM-SOLVING. A Man with Fever, Cough, and Rash. N Engl J Med. 2015 Jul 02; 373(1):74-80. PMID: 26132944.
    Citations: 1     Fields:    Translation:HumansCells
  133. Sheu J, Divito SJ, Hoffman EP, Frank NY, Merola JF. Mosaic focal dermal hypoplasia caused by a novel somatic mutation in PORCN detected in affected skin. Br J Dermatol. 2015 Aug; 173(2):568-70. PMID: 25640089.
    Citations: 2     Fields:    Translation:Humans
  134. Goyal A, Goyal K, Merola JF. Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists. Am J Clin Dermatol. 2015 Jun; 16(3):179-95. PMID: 25854805.
    Citations:    Fields:    Translation:HumansPHPublic Health
  135. Cohen JM, Husni ME, Qureshi AA, Merola JF. Psoriatic arthritis: it's as easy as "PSA". J Am Acad Dermatol. 2015 May; 72(5):905-6. PMID: 25890458.
    Citations: 1     Fields:    Translation:Humans
  136. Rao DA, Wei K, Merola JF, O'Brien WR, Takvorian SU, Dellaripa PF, Schur PH. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing. J Rheumatol. 2015 May; 42(5):847-52. PMID: 25834211.
    Citations: 2     Fields:    Translation:Humans
  137. Merola JF, Nyberg F, Furukawa F, Goodfield MJ, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP. Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire. Lupus Sci Med. 2015; 2(1):e000085. PMID: 25861460.
    Citations: 5     
  138. Varada S, Gottlieb AB, Merola JF, Saraiya AR, Tintle SJ. Treatment of coexistent psoriasis and lupus erythematosus. J Am Acad Dermatol. 2015 Feb; 72(2):253-60. PMID: 25486913.
    Citations: 3     Fields:    Translation:Humans
  139. Gottlieb AB, Levin AA, Armstrong AW, Abernethy A, Duffin KC, Bhushan R, Garg A, Merola JF, Maccarone M, Christensen R. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology. J Am Acad Dermatol. 2015 Feb; 72(2):345-8. PMID: 25486914.
    Citations: 2     Fields:    Translation:Humans
  140. Sheu J, Kattapuram SV, Stankiewicz JM, Merola JF. Eosinophilic fasciitis-like disorder developing in the setting of multiple sclerosis therapy. J Drugs Dermatol. 2014 Sep; 13(9):1144-7. PMID: 25226017.
    Citations:    Fields:    Translation:Humans
  141. Patel M, Liu SW, Qureshi A, Merola JF. The Brigham Scalp Nail Inverse Palmoplantar Psoriasis Composite Index (B-SNIPI): a novel index to measure all non-plaque psoriasis subsets. J Rheumatol. 2014 Jun; 41(6):1230-2. PMID: 24882859.
    Citations: 2     Fields:    Translation:Humans
  142. Gottlieb AB, Armstrong AW, Christensen R, Garg A, Duffin KC, Boehncke WH, Merola JF, Gladman DD, Mease PJ, Swerlick RA, Rosen CF, Abernethy A. The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting. J Rheumatol. 2014 Jun; 41(6):1227-9. PMID: 24882858.
    Citations: 2     Fields:    Translation:Humans
  143. Takvorian SU, Merola JF, Costenbader KH. Cigarette smoking, alcohol consumption and risk of systemic lupus erythematosus. Lupus. 2014 May; 23(6):537-44. PMID: 24763538.
    Citations: 14     Fields:    Translation:Humans
  144. Boehncke WH, Qureshi A, Merola JF, Thaçi D, Krueger GG, Walsh J, Kim N, Gottlieb AB. Diagnosing and treating psoriatic arthritis: an update. Br J Dermatol. 2014 Apr; 170(4):772-86. PMID: 24266754.
    Citations: 4     Fields:    Translation:Humans
  145. Merola JF, Husni ME, Qureshi AA. Psoriatic arthritis screening tools: study design and methodological challenges. Br J Dermatol. 2014 Apr; 170(4):994-5. PMID: 24400947.
    Citations:    Fields:    Translation:Humans
  146. Merola JF, Han J, Li T, Qureshi AA. No association between vitamin D intake and incident psoriasis among US women. Arch Dermatol Res. 2014 Apr; 306(3):305-7. PMID: 24232773.
    Citations: 3     Fields:    Translation:Humans
  147. Merola JF, Wu S, Han J, Choi HK, Qureshi AA. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis. 2015 Aug; 74(8):1495-500. PMID: 24651620.
    Citations: 11     Fields:    Translation:Humans
  148. Merola JF, Bermas B, Lu B, Karlson EW, Massarotti E, Schur PH, Costenbader KH. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014 Jul; 23(8):778-84. PMID: 24608964.
    Citations: 12     Fields:    Translation:Humans
  149. Eastham AB, Liang CA, Femia AN, Lee TC, Vleugels RA, Merola JF. Lupus erythematosus panniculitis-induced facial atrophy: effective treatment with poly-L-lactic acid and hyaluronic acid dermal fillers. J Am Acad Dermatol. 2013 Nov; 69(5):e260-e262. PMID: 24124855.
    Citations: 1     Fields:    Translation:Humans
  150. Frankel HC, Sharon VR, Vleugels RA, Merola JF, Qureshi AA. Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity. Int J Dermatol. 2013 Nov; 52(11):1407-9. PMID: 24164159.
    Citations: 2     Fields:    Translation:Humans
  151. Femia AN, Eastham AB, Lam C, Merola JF, Qureshi AA, Vleugels RA. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center. J Am Acad Dermatol. 2013 Oct; 69(4):654-7. PMID: 24034377.
    Citations: 4     Fields:    Translation:Humans
  152. Nguyen K, Vleugels RA, Velez NF, Merola JF, Qureshi AA. Psoriasiform reactions to anti-tumor necrosis factor a therapy. J Clin Rheumatol. 2013 Oct; 19(7):377-81. PMID: 24048106.
    Citations: 8     Fields:    Translation:Humans
  153. Merola JF, Husni ME, Qureshi AA. Screening instruments for psoriatic arthritis. J Rheumatol. 2013 Sep; 40(9):1623. PMID: 23997000.
    Citations: 1     Fields:    Translation:Humans
  154. Merola JF, Prystowsky SD, Iversen C, Gomez-Puerta JA, Norton T, Tsao P, Massarotti E, Schur P, Bermas B, Costenbader KH. Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol. 2013 Jul; 69(1):19-24. PMID: 23541758.
    Citations:    Fields:    Translation:Humans
  155. De Souza A, Strober BE, Merola JF, Oliver S, Franks AG. Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study. J Drugs Dermatol. 2012 Oct; 11(10):1224-6. PMID: 23134988.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  156. Merola JF, Ghoroghchian PP, Samuels MA, Levy BD, Loscalzo J. Clinical problem-solving. At a loss. N Engl J Med. 2012 Jul 05; 367(1):67-72. PMID: 22762321.
    Citations: 1     Fields:    Translation:Humans
  157. Vaidya A, Ghoroghchian PP, Merola JF, Samuels MA. Interactive medical case. At a loss. N Engl J Med. 2012 Jun 14; 366(24):e37. PMID: 22694019.
    Citations: 1     Fields:    Translation:Humans
  158. Girouard SD, Falk RH, Rennke HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J. 2012 Jan 15; 18(1):2. PMID: 22301039.
    Citations: 6     Fields:    Translation:Humans
  159. Merola JF, Chang CA, Sanchez MR, Prystowsky SD. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? J Drugs Dermatol. 2011 Dec; 10(12):1413-20. PMID: 22134565.
    Citations: 5     Fields:    Translation:Humans
  160. Click J, Gee S, Cortes R, Gedmintas L, Merola JF, Bykerk V, Saveedra A. Levamisole-induced retiform purpura. J Drugs Dermatol. 2011 Feb; 10(2):217. PMID: 21361080.
    Citations: 5     Fields:    Translation:Humans
  161. Farley-Loftus R, Mahlberg M, Merola JF, Votava HJ, Meehan S, Stein J, Shupack JL. Generalized discoid lupus erythematosus. Dermatol Online J. 2009 Aug 15; 15(8):18. PMID: 19891926.
    Citations:    Fields:    Translation:Humans
  162. Warycha M, Patel R, Meehan S, Merola JF. Familial benign chronic pemphigus (Hailey-Hailey disease). Dermatol Online J. 2009 Aug 15; 15(8):15. PMID: 19891923.
    Citations: 1     Fields:    Translation:Humans
  163. Merola JF, Meehan S, Walters RF, Brown L. Exogenous ochronosis. Dermatol Online J. 2008 Oct 15; 14(10):6. PMID: 19061605.
    Citations: 2     Fields:    Translation:Humans
  164. Bakst R, Merola JF, Franks AG, Sanchez M. Raynaud's phenomenon: pathogenesis and management. J Am Acad Dermatol. 2008 Oct; 59(4):633-53. PMID: 18656283.
    Citations: 21     Fields:    Translation:Humans
  165. Merola JF, Pulitzer M, Rosenman K, Brownell I. Cutaneous Rosai-Dorfman disease. Dermatol Online J. 2008 May 15; 14(5):8. PMID: 18627744.
    Citations:    Fields:    Translation:HumansCells
  166. Merola JF, Mengden SJ, Soldano A, Rosenman K. Eruptive xanthomas. Dermatol Online J. 2008 May 15; 14(5):10. PMID: 18627746.
    Citations: 2     Fields:    Translation:Humans
  167. Hatsell S, Medina L, Merola J, Haltiwanger R, Cowin P. Plakoglobin is O-glycosylated close to the N-terminal destruction box. J Biol Chem. 2003 Sep 26; 278(39):37745-52. PMID: 12847106.
    Citations: 10     Fields:    Translation:HumansCells
  168. Hodge CJ, Stevens RT, Newman H, Merola J, Chu C. Identification of functioning cortex using cortical optical imaging. Neurosurgery. 1997 Nov; 41(5):1137-44; discussion 1144-5. PMID: 9361069.
    Citations:    Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Merola's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (399)
Explore
_
Co-Authors (75)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.